IN2015MN00127A - - Google Patents

Info

Publication number
IN2015MN00127A
IN2015MN00127A IN127MUN2015A IN2015MN00127A IN 2015MN00127 A IN2015MN00127 A IN 2015MN00127A IN 127MUN2015 A IN127MUN2015 A IN 127MUN2015A IN 2015MN00127 A IN2015MN00127 A IN 2015MN00127A
Authority
IN
India
Prior art keywords
present
relates
composition
iron deficiency
solid composition
Prior art date
Application number
Other languages
English (en)
Inventor
Andrea Lacorte
Germano Tarantino
Original Assignee
Alesco Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alesco Srl filed Critical Alesco Srl
Publication of IN2015MN00127A publication Critical patent/IN2015MN00127A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
IN127MUN2015 2012-07-31 2013-07-30 IN2015MN00127A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001350A ITMI20121350A1 (it) 2012-07-31 2012-07-31 Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
PCT/IB2013/001659 WO2014009806A1 (en) 2012-07-31 2013-07-30 Solid composition comprising iron for use in iron deficient conditions

Publications (1)

Publication Number Publication Date
IN2015MN00127A true IN2015MN00127A (zh) 2015-10-16

Family

ID=46982695

Family Applications (1)

Application Number Title Priority Date Filing Date
IN127MUN2015 IN2015MN00127A (zh) 2012-07-31 2013-07-30

Country Status (24)

Country Link
US (2) US10183077B2 (zh)
EP (2) EP3498265B1 (zh)
JP (1) JP6232426B2 (zh)
CN (2) CN111265546A (zh)
BR (2) BR122022015143B1 (zh)
CA (1) CA2879681C (zh)
CY (2) CY1121435T1 (zh)
DK (2) DK3498265T3 (zh)
EA (1) EA027684B1 (zh)
ES (2) ES2830428T3 (zh)
HR (2) HRP20190461T1 (zh)
HU (2) HUE042698T2 (zh)
IL (2) IL236793A0 (zh)
IN (1) IN2015MN00127A (zh)
IT (1) ITMI20121350A1 (zh)
LT (2) LT2879667T (zh)
MA (1) MA20150375A1 (zh)
ME (1) ME03349B (zh)
PL (2) PL3498265T3 (zh)
PT (2) PT2879667T (zh)
RS (2) RS58647B1 (zh)
SI (2) SI2879667T1 (zh)
TR (1) TR201903899T4 (zh)
WO (1) WO2014009806A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121350A1 (it) 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
ITMI20131483A1 (it) 2013-09-09 2015-03-10 Alesco Srl Composizioni in forma solida a base di minerali e formulazioni orosolubili contenenti le stesse.
JP6299689B2 (ja) * 2014-07-24 2018-03-28 三生医薬株式会社 生体吸収促進剤含有組成物
JP6459129B2 (ja) * 2015-04-13 2019-01-30 富田製薬株式会社 ピロリン酸第二鉄含有粉末及びその製造方法
WO2017090198A1 (ja) * 2015-11-27 2017-06-01 太陽化学株式会社 鉄含有粉末組成物
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700089258A1 (it) * 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
IT201800006288A1 (it) * 2018-06-13 2019-12-13 Composizioni comprendenti minerali sucrosomiali contenenti sali minerali per uso nelle condizioni di deficienza di tali minerali
IT201900020290A1 (it) 2019-11-04 2021-05-04 Alesco Srl Berberina sucrosomiale®, sue composizioni e loro uso
IT201900020300A1 (it) 2019-11-04 2021-05-04 Alesco Srl Uso di berberina sucrosomiale® e sue composizioni nel trattamento di dislipidemie
IT201900020316A1 (it) 2019-11-04 2021-05-04 Alesco Srl Uso di berberina sucrosomiale® e sue composizioni nel trattamento di alterazioni del metabolismo glucidico
IT201900021564A1 (it) * 2019-11-19 2021-05-19 Neilos S R L Composizione nutraceutica o farmaceutica comprendente ferro pirofosfato per l’uso nel trattamento e/o nella prevenzione di condizioni o patologie caratterizzate da carenza di ferro
IT201900022989A1 (it) 2019-12-04 2021-06-04 Alesco Srl Formulazione in forma solida di cromo, sue composizioni e usi
IT201900023016A1 (it) * 2019-12-04 2021-06-04 Alesco Srl Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale
WO2022118274A1 (en) * 2020-12-03 2022-06-09 Neilos S.r.l. Compositions for the use in the treatment and/or prevention of iron deficiency conditions or diseases
IT202100005981A1 (it) 2021-03-12 2022-09-12 Pharmanutra S P A Composizione a base di ferro per uso in un trattamento di una infiammazione gastrointestinale in soggetti sottoposti ad un trattamento di una deficienza di ferro
IT202100011084A1 (it) 2021-04-30 2022-10-30 Pharmanutra S P A Composizione nutraceutica per uso nel trattamento della stanchezza cronica/fatigue post covid-19
WO2023033750A1 (en) * 2021-08-30 2023-03-09 Ilko Ilac Sanayi Ve Ticaret A.S. Preservative free liquid formulation of lipozomal iron

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011877A1 (en) * 1996-09-18 1998-03-26 Dragoco, Inc. Liposome encapsulated active agent dry powder composition
WO1998014072A1 (fr) 1996-10-03 1998-04-09 Taiyo Kagaku Co., Ltd. Composition minerale
JP2000300213A (ja) 1999-04-21 2000-10-31 Taiyo Kagaku Co Ltd ミネラル組成物及びミネラル強化飲食品
US6521247B1 (en) * 1999-08-13 2003-02-18 Warner Chilcott Laboratories Ireland Limited Dual iron containing nutritional supplement
JP2007224054A (ja) * 2004-02-02 2007-09-06 Taiyo Kagaku Co Ltd 鉄組成物
JP4627999B2 (ja) * 2004-02-27 2011-02-09 太陽化学株式会社 坑酸化剤
WO2005082167A1 (en) * 2004-02-27 2005-09-09 Taiyo Kagaku Co., Ltd. Minera-containing composition and method of use thereof
JP2006340613A (ja) * 2005-06-07 2006-12-21 Taiyo Kagaku Co Ltd 鉄強化用組成物
JP2006340612A (ja) * 2005-06-07 2006-12-21 Taiyo Kagaku Co Ltd ミネラル強化用組成物
WO2006137133A1 (ja) * 2005-06-22 2006-12-28 Taiyo Kagaku Co., Ltd. 鉄強化用組成物
DK1973552T3 (en) * 2005-12-23 2017-08-07 Ajay Gupta Parenteral nutritional composition containing iron
JP4673235B2 (ja) * 2006-02-16 2011-04-20 太陽化学株式会社 鉄強化食品用組成物
EP2073821B1 (en) * 2006-09-28 2012-10-24 Bayer Consumer Care AG Mixture of iron and copper salts masking metallic taste
KR101811376B1 (ko) * 2010-06-09 2017-12-22 에미스페어 테크놀로지스, 인코포레이티드 경구용 철 결핍증 치료
US20120288531A1 (en) * 2011-01-14 2012-11-15 Shmuel Tuvia pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
ITMI20121350A1 (it) 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
US9594814B2 (en) 2012-09-07 2017-03-14 Splunk Inc. Advanced field extractor with modification of an extracted field

Also Published As

Publication number Publication date
DK2879667T3 (en) 2019-04-15
CN111265546A (zh) 2020-06-12
HRP20190461T1 (hr) 2019-06-14
EA201590204A1 (ru) 2015-06-30
ES2830428T3 (es) 2021-06-03
HRP20201802T1 (hr) 2021-03-19
MA20150375A1 (fr) 2015-10-30
PT2879667T (pt) 2019-04-15
BR112015002072A2 (pt) 2017-07-04
EP3498265B1 (en) 2020-09-30
US20150250885A1 (en) 2015-09-10
CA2879681C (en) 2022-06-21
ME03349B (me) 2019-10-20
EA027684B1 (ru) 2017-08-31
US10183077B2 (en) 2019-01-22
CA2879681A1 (en) 2014-01-16
TR201903899T4 (tr) 2019-04-22
IL265561A (en) 2019-05-30
ES2719252T3 (es) 2019-07-09
BR112015002072B1 (pt) 2022-11-01
EP2879667A1 (en) 2015-06-10
DK3498265T3 (da) 2020-11-16
IL265561B (en) 2021-02-28
EP2879667B1 (en) 2019-01-16
PL3498265T3 (pl) 2021-03-08
HUE052036T2 (hu) 2021-04-28
IL236793A0 (en) 2015-03-31
EP3498265A1 (en) 2019-06-19
RS61069B1 (sr) 2020-12-31
CY1123610T1 (el) 2022-03-24
RS58647B1 (sr) 2019-05-31
SI2879667T1 (sl) 2019-07-31
CN104602674A (zh) 2015-05-06
LT2879667T (lt) 2019-05-10
US10765752B2 (en) 2020-09-08
US20190105393A1 (en) 2019-04-11
WO2014009806A1 (en) 2014-01-16
JP2015523409A (ja) 2015-08-13
JP6232426B2 (ja) 2017-11-15
ITMI20121350A1 (it) 2014-02-01
PL2879667T3 (pl) 2019-07-31
SI3498265T1 (sl) 2021-02-26
PT3498265T (pt) 2020-11-16
LT3498265T (lt) 2021-01-25
HUE042698T2 (hu) 2019-07-29
CY1121435T1 (el) 2020-05-29
BR122022015143B1 (pt) 2023-05-09

Similar Documents

Publication Publication Date Title
IN2015MN00127A (zh)
HK1214832A1 (zh) 用於代謝病症和疾病治療的組合物和方法
SG11201707657UA (en) Methods and compositions relating to microbial treatment and diagnosis of skin disorders
TN2015000026A1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
IL237369A0 (en) Methods for treating Alzheimer's disease and pharmaceutical compositions thereof
JO3199B1 (ar) مركبات 5- فلورو-1h- بيرازولوبيريدينات مستبدلة واستخدامها
IN2014MN02069A (zh)
MY169980A (en) Bisaryl-linked aryltriazolones and their use
PH12014502496B1 (en) Bicyclically substituted uracils and the use thereof
IN2014DN08761A (zh)
EP2729148A4 (en) COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE
PH12016500065A1 (en) Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof
HK1198909A1 (zh) 用於治療肝臟疾病和障礙的組合物和方法
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
MX2015008877A (es) Conjugados de disulfuro mixto de compuestos de tienopiridina y sus usos.
EP2897621A4 (en) COMPOUNDS AND COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES, PAIN AND FEVER, SKIN DISEASES, CANCER AND PRECULTURAL INJURIES
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
PH12016500608A1 (en) Cyclic thienouracil-carboxamides and use thereof
EP2866894A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF MORBUS ALZHEIMER
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.
SG10201706453XA (en) Herbal composition for treatment of gastrointestinal inflammatory diseases and method to prepare and use thereof
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
EP2855438A4 (en) Novel compounds and compositions for the treatment of respiratory disorders or diseases
TN2010000597A1 (en) Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
UA96804C2 (uk) Лікарський препарат, що включає порошок белемніту